Status:
COMPLETED
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Lead Sponsor:
Allergan
Conditions:
Keratoconjunctivitis Sicca
Eligibility:
All Genders
Brief Summary
This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baselin...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of dry eye disease
- Currently using artificial tears daily
- Male or female of legal age of consent
- Normal lid position and closure
- Exclusion Criteria
- Patients currently using cyclosporine ophthalmic emulsion 0.05%
- Participation in other investigational drug or device study
- Any current or previous topical ophthalmic or oral cyclosporine use within the last three years
Exclusion
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
781 Patients enrolled
Trial Details
Trial ID
NCT00717418
Start Date
September 1 2004
End Date
August 1 2008
Last Update
January 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilson, North Carolina, United States